LoginSignup
image de profil
Bimbam
@Klambam
1Année·

Has anyone read news about $IBRX (-2,71 %) or knows what is going on? Almost 300% in one month.

1
11 Commentaires
image de profil
Patrick ₿ateman@fastlane
1Année
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
2
•
image de profil
Yassin@RisingAktie
1Année
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
Voir toutes les 3 autres réponses
image de profil
Nico@itZNico
1Année
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
image de profil
Bimbam@Klambam
1Année
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
Afficher la réponse
image de profil
MarsEquities@CircusClown
1Année
What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.
••
Voir toutes les 2 autres réponses
Participez à la conversation
S'inscrireConnexion